It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The Markets entity brings in negative language in all three data types starting with the immediacy value sets that have supporting details for [yet more (scandals0] around [money (currency) theft]. The the immediacy sets, the primary level of support is for [pharmaceuticals scandals] to impact [supplies] of [drugs]. The [drug supply reduction] is indicated to be a [trigger] for yet more [visibility] on the part of the [congress critters] as they ['deal] with [yet more reductions (in 'lifestyle')] for [american populace].
Originally posted by orbitbaby
What if there is a shortage because they are dumping it into the water supply?
LOL! How's that for conspiracy? Sure seems like people should be a lot more
upset about things then they are. A massive narcotic dump into our water
supply would explain a lot.
Originally posted by mike203
they probably sending all those pills to japan because it look they are goin to need them for a very long time do to the radiation exposure.that may be a logical explanation!!!
shortages in antibiotics, chemotherapy drugs, diuretics, anesthetics, antipsychotics and, yes, even the basic pain-killer morphine
The Center for Drug Evaluation and Research (CDER), administered under the U.S. Food and Drug Administration (FDA), works to ensure that drugs made available to the public are safe and effective. Companies issuing a new drug are responsible for testing and submitting evidence of the drug's safety to the CDER. During this initial development process, the company usually applies for a patent.
Patent
Obtaining a patent for a new drug typically begins once it is in development and is issued for 20 years. This grants the company enough time to bring the drug to market which can take several years, leaving sufficient time for profitability and recovery of costs.
Process
Drug patents are designed to ensure that enough time is given to the company developing the new drug to research and test it without competing companies infringing on the process. Patents help protect a company's business interest as they make an investment in the costly process of bringing medicines to market.
Companies are required under 21 CFR 314.81(b)(3)(iii) to provide FDA with a six month advance notice of the discontinuation of sole source products that are life-supporting, life-sustaining or for use in the prevention of a debilitating disease or condition.